F18.950
Inhalant use, unspecified with inhalant-induced psychotic disorder with delusions
Clinical Classification Guidelines
Medical Intelligence & Overview
Inhalant-induced psychotic disorder with delusions is a mental health condition caused by the use of inhalants. Inhalants are substances commonly found in household products that are inhaled to achieve a mind-altering effect. This disorder involves the development of psychotic symptoms, especially delusions, which are false beliefs strongly held despite clear evidence to the contrary. The condition can significantly affect an individual’s perception of reality and daily functioning. While inhalant use can sometimes be temporary and resolve after cessation, the associated psychotic symptoms require medical attention for proper management.
Causes & Symptoms
Clinical Causes: Regular or heavy inhalant use, especially substances like glue, paint fumes, gasoline, aerosols, or solvents Prolonged exposure to inhalants leading to neurochemical changes in the brain Underlying mental health conditions that may predispose to substance abuse Genetic predisposition influencing susceptibility to substance use disorders Environmental factors such as peer pressure or stressors that promote inhalant use
Key Symptoms: Hallucinations, such as hearing voices or seeing things that are not present Delusions, including false beliefs that are firmly maintained, such as paranoia or grandiosity Confusion and disorganized thinking Agitation or restlessness Altered perceptions of reality Mood swings or emotional instability Impaired social or occupational functioning Potential physical signs like dizziness, nausea, or eye irritation (due to inhalant exposure)
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a comprehensive assessment by a mental health professional. This includes a detailed patient history focusing on recent inhalant use, an evaluation of mental health symptoms, and ruling out other causes of psychosis, such as schizophrenia or substance-induced psychosis from other drugs. Physical examinations and laboratory tests may be performed to detect residual inhalant substances or related physical health issues. In some cases, neuroimaging may be employed to assess the impact on the brain.
Treatment Protocols: Cessation of inhalant use through counseling and support programs Psychiatric medications such as antipsychotics to manage delusions and hallucinations Psychotherapy, including cognitive-behavioral therapy (CBT), to help understand and modify substance use behaviors and cope with psychosis Support groups and community resources to maintain sobriety and mental health Monitoring for potential withdrawal symptoms or physical health complications
Clinical Advice & FAQs
Billing Guidance
Is F18.950 a billable ICD-10 code?
Yes, F18.950 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F18.950?
Clinical documentation must specify the nature of Inhalant use, unspecified with inhalant-induced psychotic disorder with delusions and any associated comorbidities for accurate reporting.
Cite this Clinical Reference